FR2657017B1 - Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida. - Google Patents

Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.

Info

Publication number
FR2657017B1
FR2657017B1 FR9000456A FR9000456A FR2657017B1 FR 2657017 B1 FR2657017 B1 FR 2657017B1 FR 9000456 A FR9000456 A FR 9000456A FR 9000456 A FR9000456 A FR 9000456A FR 2657017 B1 FR2657017 B1 FR 2657017B1
Authority
FR
France
Prior art keywords
virus
hiv
applications
detection
peptides derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9000456A
Other languages
English (en)
Other versions
FR2657017A1 (fr
Inventor
Martin Jacques
Adda Denis
Somme Gerard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clonatec SA
Original Assignee
Clonatec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clonatec SA filed Critical Clonatec SA
Priority to FR9000456A priority Critical patent/FR2657017B1/fr
Priority to DE69129207T priority patent/DE69129207T2/de
Priority to AT91400049T priority patent/ATE164853T1/de
Priority to EP91400049A priority patent/EP0438332B1/fr
Priority to JP3023657A priority patent/JP3020289B2/ja
Publication of FR2657017A1 publication Critical patent/FR2657017A1/fr
Priority to US08/116,252 priority patent/US5480966A/en
Application granted granted Critical
Publication of FR2657017B1 publication Critical patent/FR2657017B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
FR9000456A 1990-01-16 1990-01-16 Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida. Expired - Lifetime FR2657017B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9000456A FR2657017B1 (fr) 1990-01-16 1990-01-16 Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
DE69129207T DE69129207T2 (de) 1990-01-16 1991-01-11 Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
AT91400049T ATE164853T1 (de) 1990-01-16 1991-01-11 Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
EP91400049A EP0438332B1 (fr) 1990-01-16 1991-01-11 Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA
JP3023657A JP3020289B2 (ja) 1990-01-16 1991-01-16 Ｈｉｖウイルス類のエンベロープ糖タンパク質由来のペプチド、これらのウイルスによって起こる感染の検出とエイズ症に対する予防接種へのこれらペプチドの用途
US08/116,252 US5480966A (en) 1990-01-16 1993-09-02 Peptides derived from the envelope glycoprotein of HIV viruses, their applications to the detection of infection caused by these viruses and to the vaccination against AIDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9000456A FR2657017B1 (fr) 1990-01-16 1990-01-16 Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.

Publications (2)

Publication Number Publication Date
FR2657017A1 FR2657017A1 (fr) 1991-07-19
FR2657017B1 true FR2657017B1 (fr) 1995-08-18

Family

ID=9392821

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9000456A Expired - Lifetime FR2657017B1 (fr) 1990-01-16 1990-01-16 Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.

Country Status (1)

Country Link
FR (1) FR2657017B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4228787A1 (de) * 1992-08-29 1994-03-03 Chemotherapeutisches Forschungsinstitut Georg Speyer Haus Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986006414A1 (fr) * 1985-04-29 1986-11-06 Genetic Systems Corporation Antigenes synthetiques permettant la detection d'une infection apparentee au sida
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
DE3788397T3 (de) * 1986-03-24 2003-11-27 Ortho Pharma Corp Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
EP0247557B1 (fr) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag Peptides enveloppé HTLV-III(LAV)
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
AU614521B2 (en) * 1987-04-16 1991-09-05 Johnson & Johnson Stlv-iii-related polypeptides, diagnostic systems and assay methods

Also Published As

Publication number Publication date
FR2657017A1 (fr) 1991-07-19

Similar Documents

Publication Publication Date Title
DE3787002D1 (de) Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen.
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
CO4750842A1 (es) Pox virus recombinantes de mapache y vacuna eficaz contra la infeccion del virus de inmunodeficiencia felina .
LTIP1792A (en) Aids virus envelope proteins, process for their production and purification, recombinant insect baculo-virus, vaccine against aids virus, diagnostic composition avd method of detection
DE3855947D1 (de) Peptide mit den immunologischen Eigenschaften von HIV-2
DE3855134D1 (de) Monoklonale menschliche antikörper gegen hiv-i
DE69433007D1 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus
NO871862D0 (no) Fremgangsmaate for paavisning av aids-virusinfeksjon.
DK641787A (da) Virusvektor, der koder for et glycoprotein fra det virus, der er ansvarligt for aids, vaccine, der omfatter virusvektoren eller glycoproteinet, samt antistof mod glycoproteinet
HK1044463A1 (en) Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein.
DE68910577D1 (de) Mittel gegen den AIDS-Virus.
FI872960A0 (fi) Expression av en gen av aids-virus.
FR2657017B1 (fr) Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
FR2657016B1 (fr) Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
ZA89862B (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
OA09653A (en) Rubella peptides
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
FR2620030B1 (fr) Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
CA2057612A1 (fr) Peptides selectionnes de l'antigene specifique au groupe (gag) du virus de l'immunodeficience humaine (vih), sa preparation et son utilisation
RU93058325A (ru) Применение производных 1,3-оксатиолана для получения лекарственных препаратов для лечения или профилактики вирусной инфекции гепатита в, применение производных 1,3 - оксатиолана для лечения инфекций гепатита в, способ лечения гепатита в
IT1276509B1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
EP0250128A3 (fr) Virus isolé de patients atteints du SIDA
FR2610632B1 (fr) Peptides caracteristiques des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida
FR2655855B1 (fr) Protection genetique d'animaux contre l'infection par le virus leucemogene bovin, et provirus et virus recombinant derive de ce virus.
ZA200108398B (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.

Legal Events

Date Code Title Description
ST Notification of lapse
RN Application for restoration
FC Decision of inpi director general to approve request for restoration
TP Transmission of property